Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)

Clinical trial NCT05393037 · COMPLETED

Trial details

NCT number: NCT05393037
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2022-07-13
Primary completion: 2023-07-13
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.